Amarin Corp Plc (AMRN): "On August 11, 2022, the Board held a me...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	48
Posts	5518
Boards Moderated	0
Alias Born	09/04/2009

ggwpq

Re: None

Sunday, 04/30/2023 12:11:20 PM

Sunday, April 30, 2023 12:11:20 PM

"On August 11, 2022, the Board held a meeting, with members of Prometheus management and representatives of Goldman Sachs and Latham in attendance, during which representatives of Goldman Sachs discussed current biopharmaceutical capital markets and M&A considerations, including recently announced transactions, and reviewed process and timeline considerations related to strategic partnering and financing opportunities for Prometheus. After the discussion, the Board authorized Prometheus to (i) explore potential strategic partnering and financing opportunities and (ii) taking into account a number of factors, including its familiarity with Prometheus, its reputation as an internationally recognized investment banking firm, and its substantial experience with respect to the pharmaceutical and biotechnology industries, engage Goldman Sachs as its financial advisor in connection with this review of strategic alternatives."

p-40-p45:

https://www.sec.gov/Archives/edgar/data/1718852/000119312523127473/d489453dprem14a.htm